|Bid||3,620.00 x 0|
|Ask||3,626.00 x 0|
|Day's range||3,554.00 - 3,648.00|
|52-week range||388.00 - 3,652.00|
|Beta (5Y monthly)||0.50|
|PE ratio (TTM)||110.44|
|Earnings date||22 Feb 2021|
|Forward dividend & yield||0.34 (0.96%)|
|Ex-dividend date||05 Nov 2020|
|1y target est||2,680.86|
Most readers would already know that Dechra Pharmaceuticals' (LON:DPH) stock increased by 6.8% over the past three...
Ian Page has been the CEO of Dechra Pharmaceuticals PLC (LON:DPH) since 2001, and this article will examine the...
Every investor in Cabaletta Bio, Inc. (NASDAQ:CABA) should be aware of the most powerful shareholder groups. Insiders...